{"entity":{"type":"insider","cik":"0001556064","url":"/insider/0001556064","json_url":"/insider/0001556064.json","name":"Menzel Garry E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2022-12-05","last":"2023-07-10","span_basis":"filed_date"},"name_variants":[{"name":"Menzel Garry E","source":"filing","n_filings":5,"first_seen":"2022-12-05","last_seen":"2023-07-10"}],"transactions":[{"id":8758853,"accession":"0001104659-23-079700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-079700","line_url":"/filing/0001104659-23-079700#line-1","is_derivative":false,"issuer_cik":"0001556064","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001556064","owner_cik":"0001556064","owner_name":"Menzel Garry E","owner_display_name":"Menzel Garry E","owner_url":"/insider/0001556064","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"American Depositary Shares representing Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47702.0,"shares_display":"47,702","price_per_share":0.9108,"price_display":"0.91","price_state":"stated","total_value":43446.9816,"total_display":"43,446.98","total_whole":"43,447","shares_owned_after":75056.0,"shares_owned_after_display":"75,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-10","scope":"insider"},{"id":6236827,"accession":"0000899243-22-038380","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-038380","line_url":"/filing/0000899243-22-038380#line-3","is_derivative":false,"issuer_cik":"0001556064","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001556064","owner_cik":"0001556064","owner_name":"Menzel Garry E","owner_display_name":"Menzel Garry E","owner_url":"/insider/0001556064","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":1.062,"price_display":"1.06","price_state":"stated","total_value":11682.0,"total_display":"11,682.00","total_whole":"11,682","shares_owned_after":138871.0,"shares_owned_after_display":"138,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-13","scope":"insider"},{"id":6236823,"accession":"0000899243-22-038380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-038380","line_url":"/filing/0000899243-22-038380#line-2","is_derivative":false,"issuer_cik":"0001556064","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001556064","owner_cik":"0001556064","owner_name":"Menzel Garry E","owner_display_name":"Menzel Garry E","owner_url":"/insider/0001556064","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10613.0,"shares_display":"10,613","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":11674.3,"total_display":"11,674.30","total_whole":"11,674","shares_owned_after":149871.0,"shares_owned_after_display":"149,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-13","scope":"insider"},{"id":6236817,"accession":"0000899243-22-038380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-038380","line_url":"/filing/0000899243-22-038380#line-1","is_derivative":false,"issuer_cik":"0001556064","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001556064","owner_cik":"0001556064","owner_name":"Menzel Garry E","owner_display_name":"Menzel Garry E","owner_url":"/insider/0001556064","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10325.0,"shares_display":"10,325","price_per_share":1.131,"price_display":"1.13","price_state":"stated","total_value":11677.575,"total_display":"11,677.58","total_whole":"11,678","shares_owned_after":160484.0,"shares_owned_after_display":"160,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-13","scope":"insider"},{"id":6319315,"accession":"0000899243-22-038098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-038098","line_url":"/filing/0000899243-22-038098#line-2","is_derivative":false,"issuer_cik":"0001556064","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001556064","owner_cik":"0001556064","owner_name":"Menzel Garry E","owner_display_name":"Menzel Garry E","owner_url":"/insider/0001556064","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9314.0,"shares_display":"9,314","price_per_share":1.254,"price_display":"1.25","price_state":"stated","total_value":11679.756,"total_display":"11,679.76","total_whole":"11,680","shares_owned_after":170809.0,"shares_owned_after_display":"170,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-09","scope":"insider"},{"id":6319313,"accession":"0000899243-22-038098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-038098","line_url":"/filing/0000899243-22-038098#line-1","is_derivative":false,"issuer_cik":"0001556064","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001556064","owner_cik":"0001556064","owner_name":"Menzel Garry E","owner_display_name":"Menzel Garry E","owner_url":"/insider/0001556064","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9111.0,"shares_display":"9,111","price_per_share":1.282,"price_display":"1.28","price_state":"stated","total_value":11680.302,"total_display":"11,680.30","total_whole":"11,680","shares_owned_after":180123.0,"shares_owned_after_display":"180,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2022-12-09","scope":"insider"},{"id":6118289,"accession":"0000899243-22-037941","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-037941","line_url":"/filing/0000899243-22-037941#line-2","is_derivative":false,"issuer_cik":"0001556064","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001556064","owner_cik":"0001556064","owner_name":"Menzel Garry E","owner_display_name":"Menzel Garry E","owner_url":"/insider/0001556064","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14886.0,"shares_display":"14,886","price_per_share":1.349,"price_display":"1.35","price_state":"stated","total_value":20081.214,"total_display":"20,081.21","total_whole":"20,081","shares_owned_after":189234.0,"shares_owned_after_display":"189,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-07","scope":"insider"},{"id":6118286,"accession":"0000899243-22-037941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-037941","line_url":"/filing/0000899243-22-037941#line-1","is_derivative":false,"issuer_cik":"0001556064","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001556064","owner_cik":"0001556064","owner_name":"Menzel Garry E","owner_display_name":"Menzel Garry E","owner_url":"/insider/0001556064","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8530.0,"shares_display":"8,530","price_per_share":1.372,"price_display":"1.37","price_state":"stated","total_value":11703.16,"total_display":"11,703.16","total_whole":"11,703","shares_owned_after":204120.0,"shares_owned_after_display":"204,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-05","filed_date":"2022-12-07","scope":"insider"},{"id":6854756,"accession":"0001209191-22-059881","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-059881","line_url":"/filing/0001209191-22-059881#line-2","is_derivative":false,"issuer_cik":"0001556064","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001556064","owner_cik":"0001556064","owner_name":"Menzel Garry E","owner_display_name":"Menzel Garry E","owner_url":"/insider/0001556064","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8408.0,"shares_display":"8,408","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":11687.12,"total_display":"11,687.12","total_whole":"11,687","shares_owned_after":212650.0,"shares_owned_after_display":"212,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001621227","name":"Adaptimmune Therapeutics PLC","url":"/issuer/0001621227","role":"Director","n_filings":1,"first_seen":"2023-07-10","last_seen":"2023-07-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001750019","name":"TCR2 THERAPEUTICS INC.","url":"/issuer/0001750019","role":"Director, Officer (President and CEO)","n_filings":4,"first_seen":"2022-12-05","last_seen":"2022-12-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001556064","retrieved_at":"2026-08-23T12:12:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}